|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
70,010,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$23.99 - $23.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Parker Katherine |
VP of Human Resources |
|
2017-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
31,609 |
|
- |
|
Leamon Christopher P |
Vice President of Research |
|
2016-12-30 |
4 |
S |
$2.55 |
$59,272 |
D/D |
(23,244) |
66,983 |
|
- |
|
Leamon Christopher P |
Vice President of Research |
|
2016-12-30 |
4 |
OE |
$2.10 |
$54,974 |
D/D |
26,178 |
90,227 |
|
- |
|
Low Philip S |
Chief Science Officer |
|
2016-11-15 |
4 |
OE |
$2.10 |
$32,983 |
D/D |
15,706 |
233,687 |
|
- |
|
Taylor Beth |
VP Finance & Chief Acctg Offcr |
|
2016-08-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
21,283 |
|
- |
|
Brauer Keith E |
Director |
|
2016-07-27 |
4 |
OE |
$1.91 |
$20,000 |
D/D |
10,471 |
14,971 |
|
- |
|
Ellis P Ron |
Former Dir., Pres. and CEO |
|
2016-06-24 |
4 |
D |
$3.68 |
$49,783 |
D/D |
(13,528) |
320,040 |
|
- |
|
Sherman Michael A. |
President, CEO and CFO |
|
2016-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
136,360 |
|
- |
|
Low Philip S |
Chief Science Officer |
|
2016-05-10 |
4 |
B |
$3.52 |
$40,040 |
D/D |
11,375 |
217,981 |
2.81 |
- |
|
Low Philip S |
Chief Science Officer |
|
2016-05-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,566 |
206,606 |
|
- |
|
Middleton Fred A |
Director |
|
2016-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
203,249 |
|
- |
|
Kozin Marc D |
Director |
|
2016-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
4,500 |
|
- |
|
Hanham Ann |
Director |
|
2016-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
4,500 |
|
- |
|
Meldrum Peter D |
Director |
|
2016-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
4,500 |
|
- |
|
Aplin John C |
Director |
|
2016-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
25,563 |
|
- |
|
Russell Lesley |
Director |
|
2016-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
4,500 |
|
- |
|
Brauer Keith E |
Director |
|
2016-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
4,500 |
|
- |
|
Goddard Colin |
Director |
|
2016-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
4,500 |
|
- |
|
Leamon Christopher P |
Vice President of Research |
|
2016-02-17 |
4 |
OE |
$1.91 |
$25,000 |
D/D |
13,089 |
61,548 |
|
- |
|
Brinkley Michael A. |
VP OF QUALITY |
|
2016-02-06 |
4 |
D |
$3.02 |
$1,752 |
D/D |
(580) |
14,933 |
|
- |
|
Leamon Christopher P |
Vice President of Research |
|
2016-02-06 |
4 |
D |
$3.02 |
$2,099 |
D/D |
(695) |
48,459 |
|
- |
|
Low Philip S |
Chief Science Officer |
|
2016-02-06 |
4 |
D |
$3.02 |
$2,099 |
D/D |
(695) |
218,172 |
|
- |
|
Sherman Michael A. |
COO and CFO |
|
2016-02-06 |
4 |
D |
$3.02 |
$2,096 |
D/D |
(694) |
124,972 |
|
- |
|
Harper Scot |
VP of CLINICAL OPERATIONS |
|
2016-02-06 |
4 |
D |
$3.02 |
$2,096 |
D/D |
(694) |
22,535 |
|
- |
|
Taylor Beth |
Corporate Controller |
|
2016-02-06 |
4 |
D |
$3.02 |
$1,586 |
D/D |
(525) |
16,482 |
|
- |
|
348 Records found
|
|
Page 6 of 14 |
|
|